» Articles » PMID: 34773472

DNA Damage and Repair in Peripheral Blood Mononuclear Cells After Internal Ex Vivo Irradiation of Patient Blood with I

Overview
Date 2021 Nov 13
PMID 34773472
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The aim of this study was to provide a systematic approach to characterize DNA damage induction and repair in isolated peripheral blood mononuclear cells (PBMCs) after internal ex vivo irradiation with [I]NaI. In this approach, we tried to mimic ex vivo the irradiation of patient blood in the first hours after radioiodine therapy.

Material And Methods: Blood of 33 patients of two centres was collected immediately before radioiodine therapy of differentiated thyroid cancer (DTC) and split into two samples. One sample served as non-irradiated control. The second sample was exposed to ionizing radiation by adding 1 ml of [I]NaI solution to 7 ml of blood, followed by incubation at 37 °C for 1 h. PBMCs of both samples were isolated, split in three parts each and (i) fixed in 70% ethanol and stored at - 20 °C directly (0 h) after irradiation, (ii) after 4 h and (iii) 24 h after irradiation and culture in RPMI medium. After immunofluorescence staining microscopically visible co-localizing γ-H2AX + 53BP1 foci were scored in 100 cells per sample as biomarkers for radiation-induced double-strand breaks (DSBs).

Results: Thirty-two of 33 blood samples could be analysed. The mean absorbed dose to the blood in all irradiated samples was 50.1 ± 2.3 mGy. For all time points (0 h, 4 h, 24 h), the average number of γ-H2AX + 53BP1 foci per cell was significantly different when compared to baseline and the other time points. The average number of radiation-induced foci (RIF) per cell after irradiation was 0.72 ± 0.16 at t = 0 h, 0.26 ± 0.09 at t = 4 h and 0.04 ± 0.09 at t = 24 h. A monoexponential fit of the mean values of the three time points provided a decay rate of 0.25 ± 0.05 h, which is in good agreement with data obtained from external irradiation with γ- or X-rays.

Conclusion: This study provides novel data about the ex vivo DSB repair in internally irradiated PBMCs of patients before radionuclide therapy. Our findings show, in a large patient sample, that efficient repair occurs after internal irradiation with 50 mGy absorbed dose, and that the induction and repair rate after I exposure is comparable to that of external irradiation with γ- or X-rays.

Citing Articles

Efficient delivery of anlotinib and radioiodine by long circulating nano-capsules for active enhanced suppression of anaplastic thyroid carcinoma.

Zhang L, Zhu C, Huang S, Xu M, Li C, Fu H J Nanobiotechnology. 2025; 23(1):180.

PMID: 40050959 PMC: 11884169. DOI: 10.1186/s12951-025-03223-2.


Enhanced γ-H2AX Foci Frequency and Altered Gene Expression in Participants Exposed to Ionizing Radiation During I-131 Nuclear Medicine Procedures.

Hariharan S, Seethashankar S, Kannan N, Christopher S, A A, Raavi V Nucl Med Mol Imaging. 2024; 58(6):341-353.

PMID: 39308490 PMC: 11415327. DOI: 10.1007/s13139-024-00872-3.


DNA Damage and Repair in PBMCs after Internal Ex Vivo Irradiation with [Ra]RaCl and [Lu]LuCl Mixtures.

Strobel I, Schumann S, Muller J, Buck A, Port M, Lassmann M Int J Mol Sci. 2024; 25(16).

PMID: 39201316 PMC: 11354558. DOI: 10.3390/ijms25168629.


Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid Cancer.

Schumann S, Scherthan H, Hartrampf P, Goring L, Buck A, Port M Int J Mol Sci. 2024; 25(10).

PMID: 38791531 PMC: 11122196. DOI: 10.3390/ijms25105493.


Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry.

Chen Z, Wakabayashi H, Kuroda R, Mori H, Hiromasa T, Kayano D Sci Rep. 2024; 14(1):4339.

PMID: 38383619 PMC: 10881581. DOI: 10.1038/s41598-024-54986-x.


References
1.
Aerts A, Eberlein U, Holm S, Hustinx R, Konijnenberg M, Strigari L . EANM position paper on the role of radiobiology in nuclear medicine. Eur J Nucl Med Mol Imaging. 2021; 48(11):3365-3377. PMC: 8440244. DOI: 10.1007/s00259-021-05345-9. View

2.
Eberlein U, Nowak C, Bluemel C, Buck A, Werner R, Scherthan H . DNA damage in blood lymphocytes in patients after (177)Lu peptide receptor radionuclide therapy. Eur J Nucl Med Mol Imaging. 2015; 42(11):1739-1749. PMC: 4554740. DOI: 10.1007/s00259-015-3083-9. View

3.
Eberlein U, Scherthan H, Bluemel C, Peper M, Lapa C, Buck A . DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy. J Nucl Med. 2015; 57(2):173-9. DOI: 10.2967/jnumed.115.164814. View

4.
Schumann S, Eberlein U, Muhtadi R, Lassmann M, Scherthan H . DNA damage in leukocytes after internal ex-vivo irradiation of blood with the α-emitter Ra-223. Sci Rep. 2018; 8(1):2286. PMC: 5797089. DOI: 10.1038/s41598-018-20364-7. View

5.
Ivashkevich A, Redon C, Nakamura A, Martin R, Martin O . Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research. Cancer Lett. 2011; 327(1-2):123-33. PMC: 3329565. DOI: 10.1016/j.canlet.2011.12.025. View